TrialInvestigational new drugs2021

Phase 2 study of bevacizumab plus carboplatin/nab-paclitaxel followed by bevacizumab plus nab-paclitaxel for non-squamous non-small cell lung cancer with malignant pleural effusion.

Motohiro Tamiya et al.PubMed ↗Publisher ↗

No numbers read from the abstract.